Characteristics and influencing factors of CD19+ B cell reconstitution in patients following haploidentical/mismatched hematopoietic stem cell transplantation

International Journal of Hematology

Volumn 96, Issue 1, 2012, Pages 109-121

  Xie, Min ^a   Fu, Hai Xia ^a   Chang, Ying Jun ^a   Xu, Lan Ping ^a   Liu, Dai Hong ^a   Zhang, Xiao Hui ^a   Han, Wei ^a   Liu, Kai Yan ^a   Huang, Xiao Jun ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

B cell; Cytomegalovirus; Graft versus host disease; Haploidentical; Hematopoietic stem cell transplantation; Immune reconstitution

Indexed keywords

BASILIXIMAB; CD19 ANTIGEN; CYCLOSPORIN A; GLUCOCORTICOID; HLA ANTIGEN; IMMUNOGLOBULIN G; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CELL COUNT; CELL LEVEL; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; GENE LOCUS; GRAFT VERSUS HOST REACTION; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTIGENS, CD19; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GLUCOCORTICOIDS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84864974855     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1099-5     Document Type: Article

References (35)

1. Ishaqi MK, Afzal S, Dupuis A, Doyle J, Gassas A. Early lymphocyte recovery post-allogeneic hematopoietic stem cell transplantation is associated with significant graft-versus-leukemia effect without increase in graft-versus-host disease in pediatric acute lymphoblastic leukemia. Bone Marrow Transplant. 2008;41(3):245-52. (Pubitemid 351260378)
2. Kumar S, Chen MG, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, et al. Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia. Leukemia. 2003;17(9):1865-70. (Pubitemid 37185264)
3. Pavletic ZS, Joshi SS, Pirruccello SJ, Tarantolo SR, Kollath J, Reed EC, et al. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant. 1998;21(1):33-41. (Pubitemid 28043434)
4. Storek J, Espino G, Dawson MA, Storer B, Flowers ME, Maloney DG. Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation. Blood. 2000;96(9):3290-3.
5. Corre E, Carmagnat M, Busson M, de Latour RP, Robin M, Ribaud P, et al. Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections. Haematologica. 2010;95(6):1025-9.
6. Storek J, Geddes M, Khan F, Huard B, Helg C, Chalandon Y, et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol. 2008;30(4):425-37.
7. Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood. 1990;76(8): 1647-56. (Pubitemid 20364032)
8. Kook H, Goldman F, Padley D, Giller R, Rumelhart S, Holida M, et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood. 1996;88(3):1089-97. (Pubitemid 26333336)
9. Storek J, Wells D, Dawson MA, Storer B, Maloney DG. Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. Blood. 2001;98(2):489-91.
10. Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant. 2006;38(4):291-7. (Pubitemid 44203779)
11. Lu DP, Dong L, Wu T, Huang XJ, Zhang MJ, Han W, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/ haploidentical blood and marrow transplantation can achieve comparable outcomes with HLAidentical sibling transplantation. Blood. 2006;107(8):3065-73.
12. Xiao-Jun H, Lan-Ping X, Kai-Yan L, Dai-Hong L, Huan C, Wei H, et al. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Ann Med. 2008;40(6):444-55.
13. Liu DH, Huang XJ, Liu KY, Xu LP, Chen H, Han W, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children. Biol Blood Marrow Transplant. 2008;14(4):469-77. (Pubitemid 351372751)
14. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18(4):295-304.
15. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2003;9(4):215-33. (Pubitemid 40045609)
16. Broers AE, van der Holt B, Haze S, Braakman E, Gratama JW, Lowenberg B, et al. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T celldepleted bone marrow transplantation. Exp Hematol. 2005;33(8): 912-9. (Pubitemid 40982658)
17. Maury S, Mary JY, Rabian C, Schwarzinger M, Toubert A, Scieux C, et al. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol. 2001;115(3):630-41. (Pubitemid 34015656)
18. Chang YJ, Zhao XY, Huo MR, Xu LP, Liu DH, Liu KY, et al. Immune reconstitution following unmanipulated HLA-mismatched/ haploidentical transplantation compared with HLAidentical sibling transplantation. J Clin Immunol. 2011;32(2): 268-80.
19. Borghesi LA, Smithson G, Kincade PW. Stromal cell modulation of negative regulatory signals that influence apoptosis and proliferation of B lineage lymphocytes. J Immunol. 1997;159(9): 4171-9. (Pubitemid 127470571)
20. Morrissey P, Charrier K, Bressler L, Alpert A. The influence of IL-1 treatment on the reconstitution of the hemopoietic and immune systems after sublethal radiation. J Immunol. 1988;140 (12):4204-10.
21. Krenger W, Hill GR, Ferrara JL. Cytokine cascades in acute graft-versus-host disease. Transplantation. 1997;64(4):553-8. (Pubitemid 27377183)
22. Hill GR, Krenger W, Ferrara JL. The role of cytokines in acute graft-versus-host disease. Cytokines Cell Mol Ther. 1997;3(4): 257-66.
23. LeBien TW. Fates of human B-cell precursors. Blood. 2000; 96(1):9-23.
24. Okamoto T, Kanamaru A, Kakishita E, Nagai K. Stromal fibroblastic and hematopoietic progenitors in patients with graft-versus- host disease (GVHD). Int J Hematol. 1991;54(4):299-306.
25. Garvy BA, Telford WG, King LE, Fraker PJ. Glucocorticoids and irradiation-induced apoptosis in normal murine bone marrow B-lineage lymphocytes as determined by flow cytometry. Immunology. 1993;79(2):270-7. (Pubitemid 23172223)
26. Shono Y, Ueha S, Wang Y, Abe J, Kurachi M, Matsuno Y, et al. Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation. Blood. 2010;115(26):5401-11.
27. Lonnqvist B, Ringden O, Ljungman P, Wahren B, Gahrton G. Reduced risk of recurrent leukemia in bone-marrow transplant recipients after cytomegalovirus-infection. Br J Haematol. 1986; 63(4):671-9. (Pubitemid 16033605)
28. Jacobsen N, Keiding N, Ryder L, Ringden O, Lonnqvist B, Gahrton G, et al. Graft-versus-leukaemia activity associated with cytomegalovirus antibody positive bone marrow donors in acute myeloid leukaemia. Lancet. 1987;1(8530):456-7. (Pubitemid 17016624)
29. Jacobsen N, Badsberg JH, Lonnqvist B, Ringden O, Volin L, Rajantie J, et al. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group. Bone Marrow Transplant. 1990;5(6):413-8. (Pubitemid 20344124)
30. Emery VC. Cytomegalovirus: recent progress in understanding pathogenesis and control. QJM. 2011;105(5):401-5.
31. Cobbs CS. Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis. Herpesviridae. 2011;2(1):10.
32. Preiksaitis JK, Janowska-Wieczorek A. Persistence of cytomegalovirus in human long-term bone marrow culture: relationship to hemopoiesis. J Med Virol. 1991;35(2):76-84.
33. Steinberg HN, Anderson J Jr, Lim B, Chatis PA. Cytomegalovirus infection of the BS-1 human stroma cell line: effect on murine hemopoiesis. Virology. 1993;196(2):427-32.
34. Reddehase MJ, Dreher-Stumpp L, Angele P, Balthesen M, Susa M. Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stroma. Ann Hematol. 1992;64(Suppl):A125-7.
35. Igarashi H, Medina KL, Yokota T, Rossi MI, Sakaguchi N, Comp PC, et al. Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids. Int Immunol. 2005;17(5): 501-11. (Pubitemid 41417847)